Recorded Chinese product: 穿琥宁注射液穿琥宁注射液

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

穿琥宁是一种在国家药监局注册认定的药品。该药品含有相关活性成分。

该药品关联的活性成分包括:主要成份穿琥宁Recorded Chinese composition: 主要成份穿琥宁、穿琥宁Chuanhu Ning。这些成分信息来自国家药监局数据库。

您可以探索含有相同成分的其他药品:主要成份穿琥宁-394668f3成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 穿琥宁注射液) is a medicine registered with the national drug regulatory authority. It contains active ingredient(s) as recorded.

Active ingredients associated with this product: 主要成份穿琥宁Recorded Chinese composition: Recorded Chinese name: 主要成份穿琥宁, 穿琥宁Chuanhu Ning.

Explore other medicines containing the same ingredient: products containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 穿琥宁注射液Recorded Chinese product: 穿琥宁注射液
  • 剂型Dosage form: 注射剂Injection
  • 规格Specification: 2ml:40mg2 mL:40 mg

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 广东和本堂科技制药有限公司Chinese legal name: 广东和本堂科技制药有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H20053546

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H20053546

Manufacturer

Chinese legal name: 广东和本堂科技制药有限公司

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H20053546

生产企业

广东和本堂科技制药有限公司

适应症

本品用于病毒性肺炎,病毒性上呼吸道感染等。

用法用量

1.肌肉注射。成人:一次40~80mg。一日1~2次。|2.静脉滴注。成人:一日400~800mg,用适量氯化钠注射液分二次稀释后滴注,每次不得超过400mg。

不良反应

静脉滴注后可发生过敏性休克,血小板减少,也可发生皮肤过敏(如药疹等),小儿腹泻,肝功能损害,血管刺激疼痛,胃肠不适,呼吸困难,寒战,发热等。

禁忌

对本品过敏者禁用。

注意事项

1.本品忌与酸、碱性药物或含有亚硫酸氢钠,焦亚硫酸钠为抗氧剂的药物配伍。|2.在使用过程中偶有发热、气紧现象,停止用药即恢复正常。|3.药物性状改变时禁用。|4.用药过程应定期检查血象,发现血小板减少应及时停药,并给予相应处理。

贮藏

密封,置阴凉处。

规格

2ml:40mg

证据Evidence

  • 批准文号: 国药准字H20053546
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.